HUMAN RECOMBINANT MONOCLONAL ANTIBODY AGAINST SARS-COV-2 SPIKE GLYCOPROTEIN

ANTIBODIES CAPABLE OF BINDING TO THE SPIKE PROTEIN OF CONONAVIRUS SARS-COV-2

TUMOR-SPECIFIC PAYLOAD DELIVERY AND IMMUNE ACTIVATION USING A HUMAN ANTIBODY TARGETING A HIGHLY SPECIFIC TUMOR CELL SURFACE ANTIGEN

ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF

Activin Type 2 Receptor Binding Proteins and Methods of Making Them

BISPECIFIC ANTIGEN BINDING CONSTRUCT

ANTIBODIES TO UBIQUITIN C-TERMINAL HYDROLASE L1 (UCH-L1) AND GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) AND RELATED METHODS

ANTI-TRYPTASE ANTIBODIES, COMPOSITIONS THEREOF, AND USES THEREOF

MUC16 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

Anti-human CD73 monoclonal antibody without hook effect

ANTI-BCMA ANTIBODIES AND TREATMENT METHODS

ST2 ANTIGEN BINDING PROTEINS

TMEM219 antibodies and therapeutic uses thereof

ANTI-ACVR2A ANTIBODIES AND USES THEREOF

ANTI-FRIZZLED ANTIBODIES AND METHODS OF USE

MOLECULES FOR MODULATING THE IMMUNE SYSTEM AND USES THEREOF

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

ANTI-CECAM6 ANTIBODIES WITH REDUCED SIDE-EFFECTS

METHOD OF MODULATING THE ACTIVITY OF ADRENOMEDULLIN IN A SUBJECT IN NEED OF THERAPEUTIC INTERVENTION FOR ORGAN DYSFUNCTION OR ORGAN FAILURE ASSOCIATED WITH ADRENOMEDULLIN (ADM) ACTIVITY BY ADMINISTERING AN ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR AN ANTI-ADM FRAGMENT TO THE SUBJECT

IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF

IMMUNE-STIMULATING HUMANIZED MONOCLONAL ANTIBODIES AGAINST HUMAN INTERLEUKIN-2, AND FUSION PROTEINS THEREOF

COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION

HUMANIZED ANTI-HUMAN ßIG-H3 PROTEIN AND USES THEREOF

FILAMIN A BINDING PROTEINS AND USES THEREOF

POLYPEPTIDES BINDING TO THE NEONATAL FC RECEPTOR

APPLICATION OF MULTIMER IN DETECTION AND PREPARATION OF CAR-EXPRESSING CELL

ANTI-GARP ANTIBODY

ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF

HUMANIZED ANTIBODIES THAT BIND LGR5

ANTIBODIES AND ASSAYS FOR DETECTION OF FOLATE RECEPTOR 1

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS

DOSE

ANTIBODY MOLECULES AND CONJUGATES

ANTIBODY

ANTI-PD-L1 AND IL-2 CYTOKINES

ANTI-CD3 HUMANIZED ANTIBODY

LILRB1 and LILRB2 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES AND METHOD OF USE THEREOF

BISPECIFIC ANTI-CCL2 ANTIBODIES

Antigen Binding Molecules Targeting SARS-CoV-2

IMMUNOCONJUGATE MOLECULES AND RELATED METHODS AND COMPOSITIONS THEREOF

METHODS FOR INHIBITING ANGIOGENESIS IN A SUBJECT IN NEED THEREOF

MASKED CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO TYROSINE-PROTEIN KINASE LIKE 7 (PTK7) AND IMMUNE CELLS EXPRESSING SUCH

ANTI-CD73 ANTIBODIES AND USES THEREOF

ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127

Anti-CCR8 Antibodies and Uses Thereof

Anti-CD3 Antibodies, Bispecific Antigen-Binding Molecules that Bind CD3 and CD20, and Uses Thereof

ANTI-CD48 ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND USES THEREOF

ANTI-ROR1 ANTIBODIES AND USES THEREOF

ANTI-HUMAN TSLP MONOCLONAL ANTIBODY AND USE THEREOF

PHARMACEUTICAL COMPOSITION OF ANTI-ANGPTL3 ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF AND ITS APPLICATION

HUMAN ANTIBODIES TO ARTEMIN AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR NEUTRALIZING ANTIGENS

Inhibitors of complement factor H

Antibody-drug conjugates and uses thereof

AFFINITY MOLECULES AND METHODS FOR THEIR USE

METHODS FOR OBTAINING ANTIBODY MOLECULES WITH HIGH AFFINITY

MULTIPROTEIN-ENGINEERED CELLS SECRETING A MULTISPECIFIC ANTIBODY

LOW-VISCOSITY ANTIGEN BINDING PROTEINS AND METHODS OF MAKING THEM

ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

BINDING MOLECULES THAT INHIBIT CANCER GROWTH

POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING GLYPICAN-3 AND T CELL RECEPTOR

COMPOSITIONS, DOSES, AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY

ANTIBODY MOLECULES TO PG-L1 AND METHODS OF TREATING CANCER AND INFECTIOUS DISEASES

Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs

CD123 BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS

PROTEINS THAT DECOUPLE T CELL-MEDIATED TUMOR CYTOTOXICITY FROM RELEASE OF PRO-INFLAMMATORY CYTOKINES

ANTI-CD79BxCD3 BISPECIFIC ANTIBODY AND USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS BY TARGETING IGSF8

ANTIBODIES AND MOLECULES THAT IMMUNOSPECIFICALLY BIND TO BTN1A1 AND THE THERAPEUTIC USES THEREOF

ANTI- GPRC5D ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND GPRC5D AND CD3, AND USES THEREOF

ANTIBODY VARIANTS

SCFV-FC DIMERS THAT BIND TRANSFORMING GROWTH FACTOR-BETA1 WITH HIGH AFFINITY, AVIDITY AND SPECIFICITY

IGFR-L1 ANTIBODIES AND USES THEREOF

CHARACTERIZATION OF POTENT AND BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST SARS-COV-2, ITS VARIANTS, AND RELATED CORONAVIRUSES AND METHODS OF USE

CONSTRUCTS HAVING A SIRP-ALPHA DOMAIN OR VARIANT THEREOF

Netrin-1 detection, companion test and therapy based on radiations

ANTIBODY AGAINST GLYPICAN-3 AND APPLICATION THEREOF

ANTIBODIES SPECIFICALLY BINDING TO MASP-3 FOR THE TREATMENT OF VARIOUS DISEASES AND DISORDERS

STREPTOCOCCUS PNEUMONIAE SEROTYPE-SPECIFIC DETECTION ASSAY, REAGENTS AND KITS

ENTPD2 ANTIBODIES, COMBINATION THERAPIES, AND METHODS OF USING THE ANTIBODIES AND COMBINATION THERAPIES

ANTIGEN-BINDING POLYPEPTIDES DIRECTED AGAINST CD38

ANTIBODIES TO CD40

NOVEL MULTI-SPECIFIC MOLECULES

ANTIBODIES SPECIFIC TO SIALIC ACID-BINDING IG-LIKE LECTIN 15 AND USES THEREOF

ANTI-CD47 ANTIBODIES AND USE THEREOF

NOVEL CLDN 18.2-SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF

FACTOR H POTENTIATING ANTIBODIES AND USES THEREOF

HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF

METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND USES THEREOF

METHODS AND COMPOSITIONS COMPRISING NOVEL BISPECIFIC ANTIBODIES

COMPOSITIONS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND METHODS FOR MAKING AND USING THE SAME

BINDING AGENTS TARGETING TROP2-EXPRESSING TUMOR CELLS

ANTI-BCMA ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

B CELL MATURATION ANTIGEN BINDING PROTEINS

ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF

ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF

TIE2-BINDING AGENTS AND METHODS OF USE

DUAL RECEPTOR ANTAGONISTIC ANTIGEN-BINDING PROTEINS AND USES THEREOF

Cation-Independent Mannose-6-Phosphate Receptor Binders For Targeted Protein Degradation

ANTI-ALPHA V BETA 8 INTEGRIN ANTIBODIES AND METHODS OF USE

CD8ALPHA BINDING POLYPEPTIDE AND USE THEREOF

A33 ANTIBODY COMPOSITIONS AND METHODS OF USING THE SAME IN RADIOIMMUNOTHERAPY

METHODS AND COMPOSITIONS FOR INCREASING IDURONATE 2-SULFATE ACTIVITY IN THE CNS

ANTIBODIES THAT BIND METAPNEUMOVIRUS, ANTIGENIC METAPNEUMOVIRUS PROTEINS, AND USES THEREOF

Human antibodies to ebola virus glycoprotein

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CANINES AND METHODS OF USE

INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS

NORA INHIBITORS AND METHODS OF USE

METHODS FOR DETECTING AND INHIBITING BRAIN METASTASIS

HER2 SINGLE DOMAIN ANTIBODIES VARIANTS AND CARS THEREOF

Binding agents targeting TROP2-expressing tumor cells

BINDING AGENTS TARGETING TROP2-EXPRESSING TUMOR CELLS

ANTI-TAX INTERACTING PROTEIN-1 (TIP1) BINDING MOLECULES

VARIANTS OF CD38 ANTIBODY AND USES THEREOF

Epithelial Cadherin-Specific Antibodies

BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

ANTI-HVEM ANTIBODIES

POLYPEPTIDE COMPLEXES WITH IMPROVED STABILITY AND EXPRESSION

Anti-HVEM Antibodies

ANTI-IL1RAP ANTIBODIES

B7-H4 ANTIBODY DOSING REGIMENS

ANTI-B7-H3 MONOCLONAL ANTIBODY AND USE THEREOF

ANTIBODIES AGAINST PD-L1

ANTI-CD3 ANTIBODIES

ANTI-CD3 ANTIBODY AND USE THEREOF

CELLS EXPRESSING CHIMERIC ACTIVATING RECEPTORS AND CHIMERIC STIMULATING RECEPTORS AND USES THEREOF

NOVEL DARPIN BASED CD33 ENGAGERS

Antibodies and antibody-drug conjugates targeting claudin 6

INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING

ANTIBODIES AGAINST INFLUENZA A VIRUSES

HEPATITIS B ANTIBODIES

Human Antibodies To PD-1

NOVEL ANTI-MASP-2 ANTIBODIES

NOVEL ANTI-PAD4 ANTIBODY

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

ANTI-NPR1 ANTIBODIES AND USES THEREOF

ANTI-CD25 ANTIBODY AGENTS

Anti-Trkb Monoclonal Antibodies And Methods Of Use

METHODS OF USE OF ANTI-SORTILIN ANTIBODIES FOR TREATING A DISEASE, DISORDER, OR INJURY

HUMANIZED ANTI-CLEC-1A ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF AND MIMETICS THEREOF

ANTI-B7-H4 ANTIBODIES AND USES THEREOF

ANTIGEN BINDING PROTEIN AND USE THEREOF

HUMAN ANTI-SEMAPHORIN 4D ANTIBODY

METHODS OF TREATING NEUROLOGICAL DISEASES

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE

ANTI-HUMAN INTERLEUKIN-33 MONOCLONAL ANTIBODY AND USE THEREOF

ANTIBODIES RECOGNIZING TAU

ANTI-APOE ANTIBODIES

METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF

Inverse Agonistic Anti-US28 Antibodies

ANTI-CLDN18.2 ANTIBODY CONJUGATES

RADIOLABELED MET BINDING PROTEINS FOR IMMUNO-PET IMAGING

ENHANCED TARGETING USING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

ADAM6 MICE

ANTI-STEAP1 ANTIGEN-BINDING PROTEIN

TUMOR-ASSOCIATED ANTIGENS AND CD3-BINDING PROTEINS, RELATED COMPOSITIONS, AND METHODS

HUMANIZED GPC3 ANTIBODY AND APPLICATION THEREOF

ANTI-CD73 COMPOUNDS TO TREAT ONCOVIRUS-POSITIVE CANCERS

ANTIGEN BINDING MOLECULES WITH INCREASED FC RECEPTOR BINDING AFFINITY AND EFFECTOR FUNCTION

ANTI-OX40 ANTIBODY AND USES THEREOF

ANTI-CXCR2 ANTIBODIES AND USES THEREOF

ANTIBODY MOLECULES

METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

Anti-SIRPα antibodies and methods of use thereof

Anti-PD-L1 Antibody and Usethereof

ANTIBODY SPECIFICALLY BINDING WITH PD-L1 AND ANTIGEN-BINDING FRAGMENT OF ANTIBODY

NOVEL ANTI-PD-1 ANTIBODIES

ANTIBODY MOLECULES TO CD138 AND USES THEREOF

PD-1 ANTIBODIES, POLYPEPTIDES AND USES THEREOF

BISPECIFIC ANTIBODY AND USE THEREOF

ANTI-CLDN6 AND ANTI-CD3 MULTISPECIFIC ANTIBODIES AND METHODS OF USE

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

FIBROSIS TREATMENT WITH ANTI-TREM2 ANTIBODIES

ANTI-L1CAM ANTIBODIES AND USES THEREOF

CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT REJECTION AND AUTOIMMUNE DISEASE

ANTIBODY AGAINST ADVANCED GLYCATION END PRODUCTS AND USE THEREOF

APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF

ANTI-STAPHYLOCOCCUS ANTIBODIES AND USES THEREOF

Compositions that Block Activation of the Sars-CoV-2 Replication and Transcription Complex (RTC) and Methods of Use Thereof

CHIMERIC ANTI-CORONAVIRUS SPIKE PROTEIN ANTIBODIES

TRUNCATED TACI POLYPEPTIDE AND FUSION PROTEIN AND USE THEREOF

OLIGONUCLEOTIDE CONJUGATES TARGETED TO THE TRANSFERRIN RECEPTOR

ADAPTER POLYPEPTIDES AND METHODS OF USING THE SAME

ANTI-CD72 NANOBODIES FOR IMMUNOTHERAPY

HUMANIZED ANTIBODY TO DIGOXIGENIN AND USES THEREOF

HETERODIMERIC IGA FC CONSTRUCTS AND METHODS OF USE THEREOF

BCMA Monoclonal Antibody-Drug Conjugate

HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

CEACAM5-dependent 4-1BB-agonistic bispecific antibodies

ANTIGEN BINDING MOLECULES THAT BIND LIGHT

ANTI-GIPR ANTIBODY AND METHODS OF USE THEREOF

ANTI-NR10 ANTIBODY AND USE THEREOF

IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS

ANTIBODIES

ANTI-MERTK ANTIBODIES AND METHODS OF USE THEREOF

ANTI-HLA-DQ2.5/8 ANTIBODY AND ITS USE FOR THE TREATMENT OF CELIAC DISEASE

USES OF NK CELL ENGAGING ANTIBODY FUSION CONSTRUCTS FOR TREATMENTS

HETERODIMERIC Fc VARIANTS SELECTIVE FOR Fc GAMMA RIIB

BISPECIFIC FUSION PROTEIN

ANTI-PD1 ANTIBODIES AND METHODS OF USE

ANTIGEN-BINDING PROTEINS TARGETING CD56 AND METHODS OF PRODUCING THEREOF

ANTI-NKG2A ANTIBODIES AND COMPOSITIONS

ANTI-CD300F ANTIBODY AND USES THEREOF

UNC5B FUNCTION BLOCKING ANTIBODIES

ANTIGEN-BINDING POLYPEPTIDE BINDING TO CD47, AND USE THEREOF

ANTIBODIES SPECIFIC FOR STRUCTURALLY DISORDERED SEQUENCES

ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)

NOVEL ANTIGEN BINDING MOLECULE FORMATS

BISPECIFIC ANTIBODIES FOR USE IN TREATMENT OF HIDRADENITIS SUPPURATIVA

ANTI-ERYTHROPOIETIN ANTIBODY

Modified immunoglobulins for targeting amyloid deposits

Modified immunoglobulins for targeting amyloid deposits

ANTIBODIES TO AMYLOID BETA

SERUM ALBUMIN BINDERS

ANTI-HENIPAVIRUS MONOCLONAL ANTIBODY HAVING BROAD SPECTRUM NEUTRALIZATION ACTIVITY AND USE THEREOF

CROSS-NEUTRALIZING SARS-COV2 ANTIBODIES

COMPOSITION OF PIG POLYCLONAL ANTIBODY FOR ITS USE TO TREAT AND/OR PREVENT ANTIBODY-DEPENDENT MACROPHAGE PRO-INFLAMMATORY CYTOKINE RELEASE IN A PASSIVE ANTI-INFECTIOUS IMMUNOTHERAPY

CROSS-REACTIVE ANTIBODIES RECOGNIZING THE CORONAVIRUS SPIKE S2 DOMAIN

INTERLEUKIN-15 BASED IMMUNOCYTOKINES

Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of use thereof to target dystrophin and to treat Duchenne muscular dystrophy

MESOTHELIN ISOFORM BINDING MOLECULES AND CHIMERIC PD1 RECEPTOR MOLECULES, CELLS CONTAINING THE SAME AND USES THEREOF

Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant

MATERIALS AND METHODS FOR BINDING SIGLEC-3/CD33

ANTI-TM4SF4 HUMANIZED ANTIBODY AND USE THEREOF

ANTIBODY-NKG2D LIGAND DOMAIN FUSION PROTEIN

Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

ALK7 Binding Proteins and Uses Thereof

BINDING MOLECULES SPECIFIC FOR FCGAMMA RIIA AND USES THEREOF

BISPECIFIC MOLECULE SPECIFICALLY BINDING TO B7-H3 AND TGFB AND USES THEREOF

ANTI-PDL1 ANTIBODIES AND USES THEREOF

Antibody specifically binding to ICAM-1 and use thereof

BISPECIFIC PD-1 AND TIGIT BINDING PROTEINS AND USES THEREOF

VHH-BASED NKP30 BINDERS

HIDE1 COMPOSITIONS AND METHODS

PROTEIN BINDERS TO IRHOM2 EPITOPES

METHODS OF USE OF ANTI-IL-2 ANTIBODIES

ANTI-VEGF ANTIBODY AND USE THEREOF

APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF

ANTI-C1s ANTIBODY

ANTIBODY AGAINST CORONAVIRUS

CELL-BASED ASSAY FOR DETECTING ANTl-CD3 HOMODIMERS

TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS

HUMAN-DERIVED ANTI-DIPEPTIDE REPEATS (DPRS) ANTIBODY

BIFUNCTIONAL COMPOUNDS CONTAINING IGF-2 POLYPEPTIDES

MONOVALENT ANTI-MERTK ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODIES WHICH BIND HUMAN FIBRIN OR FIBRINOGEN yC DOMAIN AND METHODS OF USE

CHIMERIC POLYPEPTIDE ASSEMBLY AND METHODS OF MAKING AND USING THE SAME

MESOTHELIN ISOFORM BINDING MOLECULES AND CHIMERIC PD1 RECEPTOR MOLECULES, CELLS CONTAINING THE SAME AND USES THEREOF

CX3CR1-BINDING POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

MAGE-A4 PEPTIDE-MHC ANTIGEN BINDING PROTEINS

MULTI-SPECIFIC ANTIBODIES AND METHODS OF USE

BISPECIFIC ANTI-MERTK AND ANTI-PDL1 ANTIBODIES AND METHODS OF USE THEREOF

CELLS EXPRESSING VISTA ANTIGEN-BINDING MOLECULES

CD28 SHEDDING BLOCKING AGENTS

MULTI-SPECIFIC ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

ANTIBODIES THAT STIMULATE NK CELL-MEDIATED CYTOTOXICITY

DUAL SPECIFIC ANTIBODIES

ANTI-CXCR5 ANTIBODIES AND COMPOSITIONS AND USES THEREOF

ANTIGEN-BINDING MOLECULE PROMOTING DISAPPEARANCE OF ANTIGENS HAVING PLURALITY OF BIOLOGICAL ACTIVITIES

ISOFORM-SELECTIVE ANTI-TGF-BETA ANTIBODIES AND METHODS OF USE

ANTIBODIES WHICH BIND HUMAN FIBRIN OR FIBRINOGEN yC DOMAIN AND METHODS OF USE

ANTIBODIES TARGETING AFP PEPTIDE/MHC COMPLEXES AND USES THEREOF

COMPOSITION COMPRISING RECOMBINANT Gplba RECEPTOR PROTEIN

VEGFR-ANTIBODY LIGHT CHAIN FUSION PROTEIN

COMPOSITIONS

ANTIBODY-UREASE CONJUGATES FOR THERAPEUTIC PURPOSES

SITE-SPECIFIC ANTIBODY-DRUG GLYCONJUGATES AND METHODS

IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS

ANTI-KLB ANTIBODIES AND USES

CELLS EXPRESSING HER3 ANTIGEN-BINDING MOLECULES

Anti-SIRP-Alpha Antibodies and Methods of Use Thereof

ANTI-CD20 ANTIBODY COMPOSITIONS

ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY ANTIBODIES

ANTI-OX40L ANTIBODY, ANTI-OX40L/ANTI-TNFa BISPECIFIC ANTIBODY, AND USES THEREOF

THERAPEUTICS AND METHODS FOR TREATING OR AMELIORATING METABOLIC DISORDERS

ENGINEERED ANTIBODY FC VARIANTS FOR ENHANCED SERUM HALF LIFE

COMBINATION THERAPIES TARGETING PD-1, TIM-3, AND LAG-3

ANTIGEN-BINDING MOLECULE COMPRISING ALTERED ANTIBODY VARIABLE REGION BINDING CD3 AND CD137

ANTI-CD2 ANTIBODIES

ANTI-TIM3 ANTIBODIES AND METHODS OF USE

BINDING AGENTS

NOVEL ANTIBODY FORMAT

HUMAN NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 SPIKE S2 DOMAIN AND USES THEREOF

ANTIBODIES THAT BIND SARS-COV-2 SPIKE PROTEIN

ANTI-SARS-COV-2 ANTIBODIES DERIVED FROM CR3022

ANTI-NECTIN-4 ANTIBODY AND ANTI-NECTIN-4 ANTIBODY-DRUG CONJUGATE, AND MEDICINAL USE THEREOF

POLYPEPTIDES TARGETING CD70-POSITIVE CANCERS

ANTI-CD47 ANTIBODY FOR COMBINED TREATMENT OF BLOOD TUMOR

ALTERNATIVE PD1-IL7V IMMUNOCONJUGATES FOR THE TREATMENT OF CANCER

SPECIFIC BINDING PROTEIN TARGETING PD-L1 AND CD73

Fusion Protein Containing BDNF

ANTI-PD-1×4-1BB BINDING PROTEINS

PROTEINS THAT BIND CD80 AND/OR CD86, AND OX40L

Human antibodies to human interleukin 18 receptor alpha or beta